Curevac Stock Analysis

CVAC -  USA Stock  

USD 54.70  40.09  42.29%

The current indifference towards the small price fluctuations of Curevac NV could raise concerns from investors as the firm it trading at a share price of 54.70 on 12,719,034 in volume. The company management teams did not add any value to Curevac NV investors in May. However, most investors can still diversify their portfolios with Curevac NV to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.44. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Curevac NV partners.
Continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Curevac NV stock analysis report makes it easy to digest most publicly released information about Curevac NV and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Curevac stock analysis module also helps to analyze the Curevac NV price relationship with some important fundamental indicators such as market cap and management efficiency.

Curevac Stock Analysis Notes

The company had not issued any dividends in recent years. CureVac B.V., a clinical-stage biopharmaceutical company, engages in developing medicines based on messenger ribonucleic acid. CureVac B.V. was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV is traded on NASDAQ Exchange in the United States. For more info on Curevac NV please contact the company at 49 7 0719 8830 or go to http://www.curevac.com.

Curevac NV Quarterly Cost of Revenue

7.12 MillionShare

Curevac NV Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Curevac NV's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Curevac NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Curevac NV has very high historical volatility over the last 90 days
Latest headline from www.equities.com: CureVac NV gains 1.2060 percent for June 14 - Equities.com

Curevac NV SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Curevac NV prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Curevac NV investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Curevac NV specific information freely available to individual and institutional investors to make a timely investment decision.

Curevac Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Curevac NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Curevac NV backward and forwards among themselves. Curevac NV's institutional investor refers to the entity that pools money to purchase Curevac NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Baillie Gifford CoCommon Shares5.8 M533.2 M
Bill Melinda Gates FoundationCommon Shares3.1 M286.7 M
Price T Rowe Associates IncCommon Shares1.4 M125.3 M
Deutsche Bank AgCommon Shares478.3 K43.7 M
Susquehanna International Group LlpPut Options476.3 K43.6 M
Dz Bank Ag Deutsche Zentral Genossenschafts Bank Frankfurt Am MainCommon Shares372.1 K34 M
Susquehanna International Group LlpCall Options318.3 K29.1 M
Susquehanna International Group LlpCommon Shares316 K28.9 M
California Public Employees Retirement SystemCommon Shares217.7 K19.9 M
Note, although Curevac NV's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Curevac Profitablity

Curevac NV's profitability indicators refer to fundamental financial ratios that showcase Curevac NV's ability to generate income relative to its revenue or operating costs. If, let's say, Curevac NV is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Curevac NV's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Curevac NV's profitability requires more research than a typical breakdown of Curevac NV's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.16) (0.17) 
Return on Average Equity(0.39) (0.40) 
Return on Invested Capital(1.69) (1.82) 
Return on Sales(2.21) (2.38) 

Management Efficiency

As of June 17, 2021, Return on Average Assets is expected to decline to -0.17. In addition to that, Return on Average Equity is expected to decline to -0.4. Curevac NV Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 1.51 Billion. The current year Current Assets is expected to grow to about 1.5 B, whereas Assets Non Current are forecasted to decline to about 111.7 M. Curevac NV management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share 4.03  3.22 
Enterprise Value over EBIT(90.90) (98.07) 
Enterprise Value over EBITDA(100.96) (108.93) 
Price to Book Value 14.84  14.75 
Tangible Assets Book Value per Share 8.48  7.13 
Enterprise Value12 B11.9 B
Tangible Asset Value1.5 B1.6 B

Technical Drivers

As of the 17th of June 2021, Curevac NV shows the Risk Adjusted Performance of 0.0463, mean deviation of 3.46, and Downside Deviation of 4.98. Curevac NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Curevac NV, which can be compared to its rivals. Please confirm Curevac NV value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Curevac NV is priced correctly, providing market reflects its regular price of 54.7 per share. Given that Curevac NV has jensen alpha of 0.1511, we suggest you to validate Curevac NV's prevailing market performance to make sure the company can sustain itself at a future point.

Curevac NV Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Curevac NV more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Curevac NV Predictive Daily Indicators

Curevac NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Curevac NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Curevac NV Forecast Models

Curevac NV time-series forecasting models is one of many Curevac NV's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Curevac NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Curevac NV Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Curevac NV stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Curevac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Curevac NV. By using and applying Curevac Stock analysis, traders can create a robust methodology for identifying Curevac entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(1.99) (2.15) 
Gross Margin 0.71  0.77 
Profit Margin(2.64) (2.85) 
CureVac B.V., a clinical-stage biopharmaceutical company, engages in developing medicines based on messenger ribonucleic acid. CureVac B.V. was founded in 2000 and is headquartered in Tbingen, Germany. Curevac NV is traded on NASDAQ Exchange in the United States.

Current Curevac Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Curevac analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Curevac analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
84.0Hold2Odds
Curevac NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Curevac analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Curevac stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Curevac NV, talking to its executives and customers, or listening to Curevac conference calls.
Curevac Analyst Advice Details

Curevac Stock Analysis Indicators

Curevac NV stock analysis indicators help investors evaluate how Curevac NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Curevac NV shares will generate the highest return on investment. By understating and applying Curevac NV stock analysis, traders can identify Curevac NV position entry and exit signals to maximize returns.
Fifty Two Week Low36.15
Fifty Two Week High56.00
Average Daily Volume Last 10 Day23.44M
Average Daily Volume In Three Month23.44M
Fifty Day Average55.90
Two Hundred Day Average55.90
Continue to Trending Equities. Note that the Curevac NV information on this page should be used as a complementary analysis to other Curevac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Curevac NV Stock analysis

When running Curevac NV stock analysis, check to measure Curevac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curevac NV is operating at the current time. Most of Curevac NV's stock examination focuses on studying past and present price action to predict the probability of Curevac NV's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Curevac NV's price. Additionally, you may evaluate how the addition of Curevac NV to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Curevac NV is measured differently than its book value, which is the value of Curevac that is recorded on the company's balance sheet. Investors also form their own opinion of Curevac NV stock's value that differs from its market value or its book value, called intrinsic value, which is Curevac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curevac NV's market value can be influenced by many factors that don't directly affect Curevac NV underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curevac NV's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Curevac NV value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curevac NV's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.